Breast cancer gene expression profiling: clinical trial and practice implications

By Loi Sherene   Desmedt Christine   Cardoso Fatima   Piccart Martine   Sotiriou Christos  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 49-58

Future Medicine

Access to resources Recommend Favorite

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-02 ,pp. : 27-41

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy-Induced Modifications to Gastrointestinal Microflora: Evidence and Implications of Change

By  

Current Drug Metabolism, Vol. 10, Iss. 1, 2009-01 ,pp. : 79-83

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer

By Hoekman K.  

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 133-155

Adis International

Access to resources Recommend Favorite

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

By Balayssac David   Ferrier Jééréémy   Descoeur Juliette   Ling Bing   Pezet Denis   Eschalier Alain   Authier Nicolas  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 407-417

Informa Healthcare

Access to resources Recommend Favorite